Recall of KARMA Corneal Inlay

According to Department of Health, Therapeutic Goods Administration, this recall involved a device in Australia that was produced by Emergo Asia Pacific Pty Ltd T/a Emergo Australia.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    RC-2015-RN-00312-1
  • Event Risk Class
    Class II
  • Event Initiated Date
    2015-04-10
  • Event Country
  • Event Source
    DHTGA
  • Event Source URL
  • Notes / Alerts
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Extra notes in the data
  • Reason
    Emergo australia is informing users that the laser-over-inlay product bulletin originally issued in november of 2013 (rc-2013-rn-01254-1) is being updated by the manufacturer (acufocus). this update includes an additional precaution regarding use of lasers with the kamra inlay in place. acufocus is recommending the removal of the inlay prior to any laser-based glaucoma therapy.
  • Action
    Emergo Australia is notifying the users of the updated instructions in the Laser-over-Inlay product bulletin.

Device

Manufacturer